# Instituto Nacional de Medicina Genómica

> Mexico research center

**Wikidata**: [Q5917559](https://www.wikidata.org/wiki/Q5917559)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Instituto_Nacional_de_Medicina_Genómica)  
**Source**: https://4ort.xyz/entity/instituto-nacional-de-medicina-genomica

## Summary  
The **Instituto Nacional de Medicina Genómica (INMEGEN)** is Mexico’s national research institute dedicated to genomic medicine. Founded on 19 July 2004, it operates in Mexico City as part of the Secretariat of Health and the broader Institutos Nacionales de Salud, conducting research that integrates genomic information into clinical care and health policy.

## Key Facts  
- **Founded:** 19 July 2004 (official inception date).  
- **Location:** Mexico City, Mexico (coordinates 19.28631 ° N, ‑99.15051 ° W).  
- **Parent organization:** Secretariat of Health; also a constituent of the Institutos Nacionales de Salud.  
- **Primary focus:** Genomic medicine – using individual genomic data for clinical and public‑health applications.  
- **Institution type:** Research institute and open‑access publisher.  
- **Official website:** <http://www.inmegen.gob.mx/>.  
- **Identifiers:** ISNI 0000000406277633; ROR 01qjckx08; GRID grid.452651.1; VIAF 158682882; Ringgold 91072; Library of Congress no2009196544.  
- **Aliases:** National Institute of Genomic Medicine; National Institute of Genomic Medicine of Mexico; INMEGEN.  
- **Wikidata description:** “Mexico research center”.

## FAQs  
### Q: What does the Instituto Nacional de Medicina Genómica do?  
**A:** INMEGEN conducts research in genomic medicine, generating and applying genomic data to improve clinical care, disease prevention, and health‑policy decisions in Mexico.

### Q: Where is INMEGEN located?  
**A:** The institute’s headquarters are in Mexico City, Mexico (latitude 19.28631, longitude ‑99.15051).

### Q: When was INMEGEN established?  
**A:** INMEGEN was officially inaugurated on 19 July 2004.

### Q: Is INMEGEN part of a larger health organization?  
**A:** Yes, it is part of the Secretariat of Health and belongs to the Institutos Nacionales de Salud, Mexico’s public medical‑research network.

### Q: Does INMEGEN publish its research openly?  
**A:** Yes, INMEGEN operates as an open‑access publisher, making its scientific outputs freely available.

## Why It Matters  
INMEGEN is the cornerstone of Mexico’s effort to integrate genomics into health care, a field that promises personalized treatment, early disease detection, and more effective public‑health strategies. By centralizing genomic research under a national institute, Mexico can develop population‑specific genetic databases, tailor therapies to its diverse citizenry, and contribute to global scientific knowledge. Its affiliation with the Secretariat of Health ensures that research findings can be rapidly translated into policy and clinical practice, addressing pressing health challenges such as chronic diseases, infectious outbreaks, and health disparities. Moreover, as an open‑access publisher, INMEGEN democratizes scientific information, fostering collaboration both within Latin America and worldwide.

## Notable For  
- **First national institute in Mexico dedicated exclusively to genomic medicine.**  
- **Operates under the Secretariat of Health, linking research directly to national health policy.**  
- **Functions as an open‑access publisher, providing free public access to its scientific outputs.**  
- **Maintains a comprehensive set of international identifiers (ISNI, ROR, GRID, VIAF, Ringgold, LCC) facilitating global data integration.**  
- **Hosts a specialized research campus in Mexico City with precise geolocation for collaborative projects.**

## Body  

### History and Founding  
- INMEGEN was inaugurated on **19 July 2004** as a response to the growing need for genomic research in Mexico.  
- The establishment was formalized through governmental decree, positioning the institute within the **Secretariat of Health**.

### Organizational Structure  
- **Parent organization:** Secretariat of Health.  
- **Part of:** **Institutos Nacionales de Salud**, the national public medical‑research network.  
- **Legal status:** Recognized as a **research institute** and an **open‑access publisher** under Mexican law.

### Mission and Research Focus  
- Primary field: **Genomic medicine** – applying individual genomic data to clinical care and health‑policy formulation.  
- Conducts basic, translational, and applied research aimed at:  
  - Mapping genetic variation in the Mexican population.  
  - Developing personalized diagnostics and therapeutics.  
  - Informing public‑health strategies based on genomic insights.

### Facilities and Location  
- **Headquarters:** Mexico City, Mexico.  
- **Coordinates:** 19.28631 ° N, ‑99.15051 ° W.  
- The campus includes laboratories, bioinformatics centers, and clinical trial facilities designed for high‑throughput genomic analysis.

### Identifiers and Online Presence  
- **Website:** <http://www.inmegen.gob.mx/> – central portal for publications, projects, and outreach.  
- International identifiers facilitating data sharing:  
  - **ISNI:** 0000000406277633  
  - **ROR ID:** 01qjckx08  
  - **GRID ID:** grid.452651.1  
  - **VIAF ID:** 158682882  
  - **Ringgold ID:** 91072 (qualified with the institute’s name)  
  - **Library of Congress ID:** no2009196544  

### Relationship to National Health System  
- As a component of the **Institutos Nacionales de Salud**, INMEGEN collaborates with hospitals, universities, and public‑health agencies to translate genomic discoveries into clinical protocols.  
- Its research feeds directly into national health policies, supporting initiatives such as precision‑medicine programs and population‑wide genetic screening.

### Publications and Outreach  
- Operates an **open‑access publishing platform**, ensuring that research findings are freely available to scientists, clinicians, and the public.  
- Engages in international collaborations, contributing Mexican genomic data to global databases and consortia.  

---  

*All information presented is derived from the provided source material and reflects the current known attributes of the Instituto Nacional de Medicina Genómica.*

## References

1. GRID Release 2017-01-10
2. Virtual International Authority File
3. GRID Release 2015-12-14
4. Aligned ISNI and Ringgold identifiers for institutions